Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson’s disease

BACKGROUND: Parkinson’s disease (PD) is characterized by intracellular alpha-synuclein (α-syn) inclusions, progressive death of dopaminergic neurons in the substantia nigra pars compacta (SNpc), and activation of the innate and adaptive immune systems. Disruption of immune signaling between the cent...

Full description

Saved in:
Bibliographic Details
Published in:J Neuroinflammation
Main Authors: Williams, Gregory P., Schonhoff, Aubrey M., Jurkuvenaite, Asta, Thome, Aaron D., Standaert, David G., Harms, Ashley S.
Format: Artigo
Language:Inglês
Published: BioMed Central 2018
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6117927/
https://ncbi.nlm.nih.gov/pubmed/30165873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-018-1286-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items